Trending
December 10, 2024

Bicycle Therapeutics Expands Clinical Advisory Board

December 10, 2024

Eikonizo Therapeutics Announces Investment by Novo Nordisk

December 10, 2024

Orthogon Therapeutics Closes $5.2M Financing

December 10, 2024

Tasca Therapeutics Launches with $52 Million Series A Financing

December 10, 2024

Compass Therapeutics Appoints Barry Shin as Chief Financial Officer

December 9, 2024

Karyopharm Appoints Brendan Strong as Senior Vice President of Investor Relations and Corporate Communications

December 9, 2024

VIVEbiotech Receives Investment from Ampersand Capital Partners

December 5, 2024

KalVista Pharmaceuticals Reports Second Fiscal Quarter Results and Provides Operational Update

December 5, 2024

Myomo Prices $15.0 Million Public Offering of Common Stock

December 5, 2024

PharmaEssentia Appoints Joseph R. Horvat as Global Chief Commercial Officer

December 5, 2024

Atlas Venture Closes $450 Million Fund XIV

December 4, 2024

ITF Therapeutics Appoints Erica L. Monaco, CPA, as Chief Operating Officer

December 4, 2024

Cellino Appoints Chris Gemmiti, Ph.D., as SVP of Therapeutics Development

December 3, 2024

Abra Health Group Expands to Connecticut with Acquisition of the Four Locations of All About Kids Pediatric Dentistry

December 3, 2024

Incendia Therapeutics Appoints Bradford Smith as Chief Financial Officer

December 2, 2024

NeuroSense Therapeutics Announces $5 Million Private Placement